Gregory I Berk's most recent trade in GT Biopharma Inc was a trade of 50,000 Option to purchase Common Stock done . Disclosure was reported to the exchange on July 15, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| GT Biopharma Inc | Gregory I Berk | Pres. of R&D, CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2022 | 50,000 | 50,000 | - | - | Option to purchase Common Stock |